Cargando…

Pin1–FOXM1 inhibitors: a potential therapeutic for metastatic melanoma?

Detalles Bibliográficos
Autor principal: de Keizer, Peter LJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094623/
https://www.ncbi.nlm.nih.gov/pubmed/30190884
http://dx.doi.org/10.2217/mmt-2016-0010
_version_ 1783347848935374848
author de Keizer, Peter LJ
author_facet de Keizer, Peter LJ
author_sort de Keizer, Peter LJ
collection PubMed
description
format Online
Article
Text
id pubmed-6094623
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-60946232018-09-06 Pin1–FOXM1 inhibitors: a potential therapeutic for metastatic melanoma? de Keizer, Peter LJ Melanoma Manag Editorial Future Medicine Ltd 2016-09 2016-08-31 /pmc/articles/PMC6094623/ /pubmed/30190884 http://dx.doi.org/10.2217/mmt-2016-0010 Text en © 2016 Peter LJ de Keizer This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Editorial
de Keizer, Peter LJ
Pin1–FOXM1 inhibitors: a potential therapeutic for metastatic melanoma?
title Pin1–FOXM1 inhibitors: a potential therapeutic for metastatic melanoma?
title_full Pin1–FOXM1 inhibitors: a potential therapeutic for metastatic melanoma?
title_fullStr Pin1–FOXM1 inhibitors: a potential therapeutic for metastatic melanoma?
title_full_unstemmed Pin1–FOXM1 inhibitors: a potential therapeutic for metastatic melanoma?
title_short Pin1–FOXM1 inhibitors: a potential therapeutic for metastatic melanoma?
title_sort pin1–foxm1 inhibitors: a potential therapeutic for metastatic melanoma?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094623/
https://www.ncbi.nlm.nih.gov/pubmed/30190884
http://dx.doi.org/10.2217/mmt-2016-0010
work_keys_str_mv AT dekeizerpeterlj pin1foxm1inhibitorsapotentialtherapeuticformetastaticmelanoma